Articles

PP21 The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results from a multicenter study

BJH - 2018, issue Abstract Book BHS, february 2018

B. Stamatopoulos , T. Smith , E. Crompot , K. Pieters , R. Clifford , M. Mraz , P. Robbe , A. Burns , A. Timbs , D. Bruce , P. Hillmen , N. Meuleman MD, PhD, P. Mineur MD, R. Firescu , M. Maerevoet MD, V. De Wilde MD, PhD, A. Efira MD, J. Philippé MD, PhD, B. Verhasselt MD, PhD, F. Offner MD, PhD, A. Heger , D. Sims , H. Dreau , A. Schuh

Read more

O.6 Effect of bone marrow-mesenchymal stromal cell derived extracellular vesicles on survival, migration and chemoresistance of Chronic Lymphocytic Leukemia B-cells

BJH - volume 7, issue Abstract Book BHS, january 2016

E. Crompot , M. Van Damme , K. Pieters , N. Meuleman MD, PhD, D. Bron MD, PhD, P. Mineur MD, L. Lagneaux , B. Stamatopoulos

Read more

P1.16 Monoclonal B-cell lymphocytosis (MBL): results olmpact of extracellular vesicles from mesenchymal stromal cells-based microenvironment on Chronic Lymphocytic Leukemia B-cells

BJH - volume 6, issue Abstract Book BHS, january 2015

E. Crompot , M. Van Damme , H. Duvillier , K. Pieters , P. Mineur MD, N. Meuleman MD, PhD, D. Bron MD, PhD, L.L. Lagneaux , B. Stamatopoulous

Read more

P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells

BJH - volume 5, issue Abstract Book BHS, january 2014

T. André , M. Najar , B. Stamatopoulos , K. Pieters , O. Pradier MD, PhD, D. Bron MD, PhD, N. Meuleman MD, PhD, L. Lagneaux

Read more